Truist Financial Raises Tenet Healthcare (NYSE:THC) Price Target to $270.00

Tenet Healthcare (NYSE:THC) had its price target raised by research analysts at Truist Financial from $240.00 to $270.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s target price suggests a potential upside of 16.04% from the stock’s current price.

A number of other equities analysts also recently commented on THC. Barclays lifted their price target on Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a research note on Friday. JPMorgan Chase & Co. lifted their target price on Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Morgan Stanley restated an “overweight” rating and set a $260.00 price objective on shares of Tenet Healthcare in a research note on Thursday. Jefferies Financial Group boosted their target price on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Finally, Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 31st. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $246.71.

Tenet Healthcare Stock Up 0.7%

Shares of Tenet Healthcare stock traded up $1.58 on Tuesday, hitting $232.68. 253,196 shares of the company’s stock traded hands, compared to its average volume of 1,050,829. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. The firm’s 50-day moving average is $199.32 and its 200 day moving average is $195.68. The stock has a market cap of $20.45 billion, a P/E ratio of 15.02, a PEG ratio of 0.96 and a beta of 1.45. Tenet Healthcare has a 52-week low of $109.82 and a 52-week high of $235.77.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.08 by $0.62. The firm had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s quarterly revenue was up 8.9% on a year-over-year basis. During the same period in the prior year, the company posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities analysts anticipate that Tenet Healthcare will post 12.24 earnings per share for the current year.

Insider Activity at Tenet Healthcare

In related news, Director Nadja West sold 2,178 shares of the stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the sale, the director owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This trade represents a 7.10% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.81% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

Several large investors have recently made changes to their positions in THC. Boston Partners increased its position in shares of Tenet Healthcare by 15.7% during the 4th quarter. Boston Partners now owns 3,642,136 shares of the company’s stock valued at $723,804,000 after purchasing an additional 494,581 shares during the period. Ameriprise Financial Inc. grew its holdings in Tenet Healthcare by 8.0% during the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after acquiring an additional 157,109 shares during the period. AQR Capital Management LLC lifted its holdings in Tenet Healthcare by 62.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after acquiring an additional 720,160 shares during the last quarter. Norges Bank acquired a new position in shares of Tenet Healthcare in the 4th quarter worth approximately $248,494,000. Finally, Nuveen LLC raised its holdings in shares of Tenet Healthcare by 12.0% in the 4th quarter. Nuveen LLC now owns 1,155,677 shares of the company’s stock worth $229,656,000 after purchasing an additional 124,223 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.